Melanoma
Conference Coverage
Checkpoint inhibitor skin side effects more common in women
"Clinicians should consider these results in counseling female patients regarding an elevated risk of dermatologic adverse events."
Conference Coverage
For diagnosing skin lesions, AI risks failing in skin of color
AI-aided diagnostic algorithms will not work in skin of color if machine training remains inadequate.
Clinical Insights
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
From the Journals
Hyperprogression on immunotherapy: When outcomes are much worse
From the Journals
Teen tanning bed ban would prevent more than 15,000 melanoma cases
As a public health intervention, ban compares favorably with smoking education campaigns and breast cancer screening.
Conference Coverage
Made-to-order TILs effective against metastatic melanoma
Clinical Insights
Leveraging the microbiome to enhance cancer treatment
Dr. Alan Lyss reviews research suggesting that an antibiotic can improve the efficacy of radiotherapy.
Conference Coverage
Tebentafusp improves OS: A first in metastatic uveal melanoma
Tebentafusp prolonged overall survival by nearly 6 months.
From the Journals
Adverse reactions to immunotherapy can appear after a year
Latest News
Rankings of most common cancers to shift over next 20 years
“It’s time to shift focus to some of the less commonly diagnosed cancers with the lowest survival rates, like pancreatic and liver cancer.”
Conference Coverage
Melanoma presents at later stages, but at an earlier age in Asian Americans
The findings are consistent with previous studies indicating delayed detection of melanoma in Asians, compared with non-Hispanic Whites.